News
A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
14h
Health and Me on MSNDiabetes, Obesity And Cancer: Top 10 Drugs Of 2025 Are Changing How We Fight DiseaseFrom cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...
Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...
Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
Mounjaro has become popular as a weight loss drug but it also seems to be linked to hair loss in some cases in a worrying new ...
Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...
Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
Eli Lilly and Company, Thermo Fisher Scientific, and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are equity shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results